Shortage Watch Free FDA drug-shortage watch

← all medications

Chlorothiazide Oral Suspension

Brand names: Diuril

Category: Cardiovascular

Not specified 1

FDA status: To Be Discontinued · Last FDA update: Feb 10, 2026 · First posted: Feb 10, 2026 · 1 manufacturers, 1 listed presentations

As of Feb 10, 2026, the FDA lists Chlorothiazide Oral Suspension as being discontinued. Of 1 manufacturer presentations, 1 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Chlorothiazide Oral Suspension is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
Presentation & package NDCManufacturerAvailabilityFDA note
Diuril, Oral Suspension, 250 mg/5mL (NDC 65649-311-12)
NDC 65649-311-12
Salix Pharmaceuticals, a division of Bausch Health US, LLC Not specified -

Related medications in shortage

Other Cardiovascular medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Chlorothiazide Oral Suspension (FDA data as of Feb 10, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Chlorothiazide Oral Suspension. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Chlorothiazide Oral Suspension.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/chlorothiazide-oral-suspension.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).